NASDAQ
AGRX

Agile Thrpe

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Agile Thrpe Stock Price

Vitals

Today's Low:
$2.07
Today's High:
$2.3
Open Price:
$2.23
52W Low:
$0.175
52W High:
$11.396
Prev. Close:
$2.25
Volume:
22000

Company Statistics

Market Cap.:
$10.82 million
Book Value:
0.16
Revenue TTM:
$8.40 million
Operating Margin TTM:
-677.39%
Gross Profit TTM:
$-6617000
Profit Margin:
0%
Return on Assets TTM:
-129.01%
Return on Equity TTM:
-791.13%

Company Profile

Agile Thrpe had its IPO on 2014-05-23 under the ticker symbol AGRX.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Agile Thrpe has a staff strength of 30 employees.

Stock update

Shares of Agile Thrpe opened at $2.23 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.07 - $2.3, and closed at $2.14.

This is a -4.89% slip from the previous day's closing price.

A total volume of 22,000 shares were traded at the close of the day’s session.

In the last one week, shares of Agile Thrpe have slipped by -14.74%.

Agile Thrpe's Key Ratios

Agile Thrpe has a market cap of $10.82 million, indicating a price to book ratio of 1.2457 and a price to sales ratio of 0.9136.

In the last 12-months Agile Thrpe’s revenue was $8.40 million with a gross profit of $-6617000 and an EBITDA of $-54896000. The EBITDA ratio measures Agile Thrpe's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Agile Thrpe’s operating margin was -677.39% while its return on assets stood at -129.01% with a return of equity of -791.13%.

In Q3, Agile Thrpe’s quarterly earnings growth was a positive 0% while revenue growth was a positive 133.3%.

Agile Thrpe’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-11.23 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Agile Thrpe’s profitability.

Agile Thrpe stock is trading at a EV to sales ratio of 0.452 and a EV to EBITDA ratio of -0.0576. Its price to sales ratio in the trailing 12-months stood at 0.9136.

Agile Thrpe stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$18.46 million
Total Liabilities
$11.65 million
Operating Cash Flow
$0
Capital Expenditure
$126000
Dividend Payout Ratio
0%

Agile Thrpe ended 2024 with $18.46 million in total assets and $0 in total liabilities. Its intangible assets were valued at $18.46 million while shareholder equity stood at $6.34 million.

Agile Thrpe ended 2024 with $0 in deferred long-term liabilities, $11.65 million in other current liabilities, 4000.00 in common stock, $-430771000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $6.15 million and cash and short-term investments were $6.15 million. The company’s total short-term debt was $1,595,000 while long-term debt stood at $0.

Agile Thrpe’s total current assets stands at $15.49 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $3.71 million compared to accounts payable of $4.91 million and inventory worth $1.80 million.

In 2024, Agile Thrpe's operating cash flow was $0 while its capital expenditure stood at $126000.

Comparatively, Agile Thrpe paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$2.14
52-Week High
$11.396
52-Week Low
$0.175
Analyst Target Price
$3

Agile Thrpe stock is currently trading at $2.14 per share. It touched a 52-week high of $11.396 and a 52-week low of $11.396. Analysts tracking the stock have a 12-month average target price of $3.

Its 50-day moving average was $2.58 and 200-day moving average was $7.55 The short ratio stood at 0.64 indicating a short percent outstanding of 0%.

Around 15.9% of the company’s stock are held by insiders while 354.1% are held by institutions.

Frequently Asked Questions About Agile Thrpe

The stock symbol (also called stock or share ticker) of Agile Thrpe is AGRX

The IPO of Agile Thrpe took place on 2014-05-23

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$0.16
0.02
+12.89%
$89.92
-1.83
-1.99%
$0.16
0.02
+15.94%
$46.5
-0.61
-1.29%
$31.2
-2.21
-6.61%
$43.59
-0.77
-1.74%
$22.52
0.24
+1.08%
REC Ltd (RECLTD)
$248.45
-21.65
-8.02%
$6.05
-0.12
-1.94%
$445.1
-16.5
-3.57%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Agile Therapeutics, Inc., a women’s healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Address

500 College Road East, Princeton, NJ, United States, 08540